By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
While CLX offers a higher yield and appears cheap on certain metrics, its high debt-to-equity ratio (9.0x) and tight current ratio (0.8x) pose significant solvency risks, particularly in a high-rate environment or if consumer spending weakens. PG, with its fortress balance sheet and higher free cash flow, is considered the safer bet for sustainable dividends.
Risk: CLX's high debt-to-equity ratio and tight current ratio, which could lead to solvency issues if consumer spending weakens or rates stay elevated.
Opportunity: PG's strong balance sheet and high free cash flow, which make it a more durable dividend grower and downside hedge.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Are you seeking stability or value in the household goods market? Comparing Procter & Gamble(NYSE:PG) and Clorox(NYSE:CLX) reveals two distinct paths for conservative investors today.
Procter & Gamble is a global behemoth with a massive portfolio of diverse household brands, while Clorox focuses on specialized cleaning and wellness products with a smaller footprint. Both are defensive stalwarts, yet their scale and balance sheet health vary significantly.
The case for Procter & Gamble
Procter & Gamble operates through ten distinct categories, including grooming, health care, and beauty. Its products reach consumers in over 180 countries, making it one of the largest consumer staples companies by market cap. While its global reach is wide, the company depends heavily on Walmart for approximately 16% of its sales. Customer concentration like this adds a layer of risk to the business, as any change in shelf space or pricing terms could impact results.
In its 2025 fiscal year, ended June 30, revenue reached $84.3 billion, representing a slight growth of 0.3% compared to the prior year. Net income for the period was $15.7 billion, yielding a net margin of 19%. This margin, which measures the percentage of revenue remaining after all expenses are paid, indicates how much profit is generated from each dollar of sales.
As of the June 2025 balance sheet, the debt-to-equity ratio was 0.7x. This metric compares total debt to shareholder equity, indicating how much of the company is funded by lenders versus owners. The current ratio, which measures the ability to pay short-term debts with liquid assets, was 0.7x. Free cash flow for the year was $14 billion, representing cash from operations minus money spent on capital expenditures.
The case for Clorox
The Clorox Company maintains a portfolio focused on cleaning, wellness, and household convenience. Its brands, such as Pine-Sol, Glad, and Burt's Bees, are staples in many homes and professional settings. Like its larger peer, the company faces significant customer concentration, with Walmart accounting for nearly 27% of fiscal 2025 sales. Such heavy reliance on a single retailer can make the business vulnerable to changes in purchasing patterns or retail floor-space allocations.
During its 2025 fiscal year, which also ended June 30, revenue was $7.1 billion, reflecting a modest growth of about 0.2% over the previous year. Net income for the fiscal period reached $810.0 million, compared to just $280.0 million in the prior year. This performance led to a net margin of 11.4%, which measures how efficiently the firm turns revenue into profit after taxes and costs.
Based on its June 2025 financial report, the debt-to-equity ratio was 9.0x. This indicates a high level of debt relative to shareholder equity, which is a common point of analysis for capital-intensive companies. The current ratio stood at 0.8x, a metric that helps investors assess short-term liquidity and the ability to cover immediate bills. Free cash flow for the year was $761.0 million, calculated as operating cash flow minus expenditures on physical assets.
Risk profile comparison
Procter & Gamble faces intense competition from global rivals such as Unilever. These competitors often battle for shelf space and consumer loyalty through aggressive marketing and pricing. The company also deals with geopolitical instability and trade controls, which can disrupt global manufacturing networks. Furthermore, cyber-attacks or IT failures pose a constant threat to its complex international operations.
Clorox deals with heavy competition from both name brands and lower-priced private label products. Larger competitors such as Colgate-Palmolive may have more financial resources to capture market share. The company is also exposed to supply chain volatility, particularly regarding the cost of raw materials like resin and energy. Geopolitical conflicts and inflation also threaten to squeeze profitability if higher costs cannot be passed to consumers.
Valuation comparison
Clorox currently trades at a lower P/S ratio relative to both its larger rival and its expected Forward P/E.
Metric
The Procter & Gamble
The Clorox
Sector Benchmark
Forward P/E
20.8x
17.4x
25.5x
P/S ratio
4.0x
1.6x
Sector benchmark uses the SPDR XLP sector ETF. Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?
Choosing to invest in Procter & Gamble or Clorox is a good move to add defensive stocks to a portfolio. However, neither is a high-growth company, so investors would be buying primarily for their dividend income.
From that perspective, Procter & Gamble offers a robust dividend yield of 2.9% as of May 28. Clorox provides a far higher dividend yield of 5.1%, which makes it appear to be the better buy. But there’s an important consideration here.
The ability to pay dividends is determined based on available free cash flow (FCF). Procter & Gamble generates robust FCF. In its latest fiscal quarter, ended March 31, the company produced adjusted FCF of $3.0 billion, an increase over the prior year’s $2.8 billion. Rising FCF is a good sign that Procter & Gamble can not only maintain its dividend, but afford to raise it as well.
Clorox generates much lower FCF, but it grew FCF to $761 million in fiscal year 2025 compared to $483 million in 2024. The company is also undertaking initiatives to reduce its expenditures and streamline operations, which point to the potential for further improvements in FCF.
But given Procter & Gamble‘s far greater FCF amount, it would be my choice to invest in over Clorox, even though the latter has the higher dividend yield.
Should you buy stock in Procter & Gamble right now?
Before you buy stock in Procter & Gamble, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Procter & Gamble wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,072!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,303,352!*
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Robert Izquierdo has positions in Walmart. The Motley Fool has positions in and recommends Colgate-Palmolive and Walmart. The Motley Fool recommends Unilever. The Motley Fool has a disclosure policy.
Four leading AI models discuss this article
"CLX's discounted valuation and FCF turnaround outweigh its leverage risk relative to PG."
The article concludes PG is the safer 2026 pick over CLX for sustainable dividends given its $14B FCF and 0.7x debt-to-equity versus CLX's 9.0x leverage. However, this overlooks CLX trading at 17.4x forward P/E and 1.6x P/S—well below PG's 20.8x/4.0x and the XLP sector—while CLX net income surged to $810M in FY2025 with FCF up 57% YoY. PG's 0.3% revenue growth and 16% Walmart exposure carry similar concentration risks. CLX's 5.1% yield could deliver superior total returns if debt reduction continues.
CLX's 9.0x debt-to-equity leaves little margin for error on raw material inflation or retailer pushback, potentially forcing a dividend cut that PG's balance sheet can easily avoid.
"CLX's 5.1% dividend yield is a value trap—the 9.0x debt-to-equity ratio and 0.8x current ratio suggest dividend cuts are more likely than increases if economic conditions deteriorate."
The article's dividend-focused framing masks a solvency crisis at CLX. Yes, CLX yields 5.1% vs PG's 2.9%, but CLX's 9.0x debt-to-equity is catastrophic—nearly 13x worse than PG's 0.7x. CLX generated only $761M FCF on $7.1B revenue (10.7% FCF margin) versus PG's $14B on $84.3B (16.6% margin). CLX's current ratio of 0.8x signals liquidity stress. The article treats CLX's FCF growth (58% YoY) as encouraging, but from a $483M base—still fragile. PG's fortress balance sheet and 2.9% yield backed by $14B FCF is far safer. The article's conclusion favoring PG is correct, but understates how precarious CLX's leverage is if consumer spending weakens or rates stay elevated.
CLX's 9.0x leverage might be sustainable if its 11.4% net margin and improving FCF trajectory continue; the article doesn't disclose whether CLX's debt is investment-grade or refinancing risk, which could materially change the risk calculus.
"PG's superior balance sheet and free cash flow generation make it the only reliable defensive play, while CLX's extreme leverage poses a structural risk to its dividend sustainability."
The article frames this as a choice between stability and yield, but it misses the fundamental divergence in capital structure. PG is a fortress with a 0.7x debt-to-equity ratio, allowing it to navigate high-rate environments and fund R&D without dilution. Conversely, CLX’s 9.0x debt-to-equity ratio is a massive red flag, suggesting it is essentially a levered play on margin recovery rather than a pure defensive stalwart. While CLX looks 'cheap' on a P/S basis, its balance sheet fragility makes that valuation a value trap. Investors chasing the 5.1% yield are ignoring the significant interest expense risk that could force a dividend cut if consumer spending softens further in 2026.
CLX’s aggressive cost-cutting and operational streamlining could lead to massive margin expansion, making its current high leverage a non-issue if cash flow conversion accelerates as projected.
"Procter & Gamble offers the best combination of free cash flow, diversified exposure, and downside resilience for 2026, making it the safer pick among consumer staples vs Clorox."
Article frames PG as the safer bet thanks to higher free cash flow and scale, but it omits CLX’s potential to improve margins via cost cuts and portfolio optimization. The strongest overlooked risk: Clorox’s 9.0x debt-to-equity, which leaves it vulnerable if rates stay high or raw-material costs rebound. Walmart accounts for 27% of CLX’s sales vs ~16% for PG, a bigger concentration tail risk. Currency moves and supply-chain shocks could bite both, but CLX’s leverage makes them costlier to weather. In 2026, CLX could surprise on FCF, yet PG remains the more durable dividend grower and downside hedge.
CLX could surprise on FCF and margins if cost-cutting sticks and private-label pressure eases, potentially re-rating the stock despite leverage. Meanwhile, PG’s Walmart exposure and macro risk could weigh on its dividend growth in a downturn.
"CLX liquidity concerns may ease with FCF gains while PG faces comparable retailer-driven margin risks that could erode its edge."
Claude flags CLX's 0.8x current ratio as a solvency red flag, but this overlooks how CLX's 58% FCF jump could rapidly improve liquidity if sustained through further cost discipline. Meanwhile PG's minimal 0.3% revenue growth and heavy Walmart reliance create parallel risks of margin compression that might narrow its FCF superiority faster than expected in a high-rate environment.
"CLX's leverage risk hinges on debt maturity profile and rating, not the raw 9.0x multiple—a critical omission from all panelists."
Claude and Gemini both cite CLX's 0.8x current ratio as solvency stress, but neither addresses what that ratio actually means operationally. A 0.8x current ratio is tight but not catastrophic for a CPG company with predictable cash conversion—Colgate trades similarly. The real question: is CLX's debt refinancing-risk or structurally sustainable? If CLX's debt is investment-grade and maturities are laddered, the leverage narrative weakens. If it's sub-investment-grade with near-term maturities, Claude's caution is justified. The article omits this entirely.
"The risk to CLX is not just leverage, but the extreme revenue concentration with Walmart which limits their pricing power."
Claude and Gemini are fixated on the 9.0x debt-to-equity ratio, but they ignore the composition of that debt. If CLX’s debt is primarily long-term, fixed-rate notes, the 'solvency crisis' narrative is overblown. The real risk isn't the leverage itself, but the 27% Walmart concentration mentioned by ChatGPT. If Walmart flexes its muscle to squeeze supplier margins, CLX’s thin liquidity will evaporate regardless of their cost-cutting initiatives. We are debating balance sheets while ignoring the retailer-driven margin compression risk.
"The real CLX risk is retailer-margin pressure and debt-profile dynamics that can erode FCF and liquidity, even if the current ratio looks manageable."
Claude's 0.8x current ratio discussion misses the debt-maturity ladder and covenant headroom. The bigger risk for CLX isn't solvency doom but ongoing retailer margin pressure and a logistics-cost environment that could erode FCF even with cost cuts. If Walmart squeezes supplier margins or requires extended terms, liquidity could strain before debt refinances mature. CLX’s leverage is a risk multiplier, not a standalone fatal flaw.
While CLX offers a higher yield and appears cheap on certain metrics, its high debt-to-equity ratio (9.0x) and tight current ratio (0.8x) pose significant solvency risks, particularly in a high-rate environment or if consumer spending weakens. PG, with its fortress balance sheet and higher free cash flow, is considered the safer bet for sustainable dividends.
PG's strong balance sheet and high free cash flow, which make it a more durable dividend grower and downside hedge.
CLX's high debt-to-equity ratio and tight current ratio, which could lead to solvency issues if consumer spending weakens or rates stay elevated.